PON2 and obesity due to melanocortin 4 receptor deficiency: Given that PON2 reduces oxidative stress-mediated toxicity, it is possible that increasing its levels in the airway epithelial cells could provide therapeutic benefits to subjects with obesity and asthma [16–21].